EquityAnlon Healthcare IPO Listing: Pharma Company's Shares Make Flat Debut On NSE and BSEBY Outlook Money
EquityGST Council Meeting, US Manufacturing PMI And Other Key Market Cues To Watch TodayBY Outlook Money
EquityAmanta Healthcare IPO: Issue Booked Over 10 Times So Far, Check GMP And Other Key DetailsBY Ayush Khar
EquitySebi Outlines New Framework For Monitoring Of Intraday Position Limits For Index DerivativesBY Ayush Khar
EquityOla Electric, Ather Energy Vroom Up To 14 Per Cent – Know Which EV Stock Has Made IPO Investors RicherBY Outlook Money
EquityAmanta Healthcare IPO GMP: Pharma Company's Public Issue Fully Subscribed Within First Hour of BiddingBY Ayush Khar
EquityMarket Cues Today: Trump’s EU Threat, SCO Meeting, Crude Oil Prices And Other Factors Set To Impact D-StreetBY Outlook Money
EquityReliance Jio IPO: Will It Be India’s Biggest Public Issue? Here’s What We Know So FarBY Outlook Money
EquityFPIs Offload Rs 39,000 Crore In August, Buy Rs 4,070 Crore Through IPOs – Here’s WhyBY Outlook Money
EquityMarket Cues This Week: SCO Summit, GST Council Meeting, And Other Factors That Will Likely Impact D-StreetBY Outlook Money
EquityUpcoming IPOs In First Week of September 2025: Amanta Healthcare IPO And 7 Other Public Issues Set To OpenBY Ayush Khar
EquityAnlon Healthcare IPO GMP Indicates Modest Debut, Check Steps To View Share Allotment Status And Other DetailsBY Ayush Khar
EquityAnlon Healthcare IPO GMP: Pharmaceutical Product Maker’s Public Issue Booked More Than 6 Times On Day 3BY Ayush Khar
EquityMarket Cues Today: FM’s Assurance To Exporters, Crude Oil Prices And Other Factors Likely To Affect D-Street TodayBY Outlook Money
EquityVikran Engineering IPO Day 2: EPC Company's Issue Oversubscribed More Than 5 Times, Check GMP And Other Key DetailsBY Ayush Khar
EquityAnlon Healthcare IPO: Key Things To Know About Pharmaceutical Company’s Public IssueBY Ayush Khar
